Singapore markets closed

Sumitomo Pharma Co., Ltd. (DNPUF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
2.2600-0.3550 (-13.58%)
At close: 03:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 994.60M
Enterprise value 3.37B
Trailing P/E N/A
Forward P/E 15.22
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.41
Price/book (mrq)0.82
Enterprise value/revenue 1.73
Enterprise value/EBITDA -0.03

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 3-54.46%
S&P500 52-week change 326.25%
52-week high 34.3700
52-week low 31.9900
50-day moving average 32.3154
200-day moving average 32.7845

Share statistics

Avg vol (3-month) 31.14k
Avg vol (10-day) 3N/A
Shares outstanding 5397.29M
Implied shares outstanding 6499.8M
Float 8169.56M
% held by insiders 157.59%
% held by institutions 116.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.1
Forward annual dividend yield 44.05%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 430 Mar 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -100.13%
Operating margin (ttm)-298.49%

Management effectiveness

Return on assets (ttm)-21.74%
Return on equity (ttm)-111.89%

Income statement

Revenue (ttm)314.56B
Revenue per share (ttm)791.76
Quarterly revenue growth (yoy)-16.50%
Gross profit (ttm)N/A
EBITDA -317.37B
Net income avi to common (ttm)-314.97B
Diluted EPS (ttm)-4.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.13B
Total cash per share (mrq)90.95
Total debt (mrq)427.86B
Total debt/equity (mrq)274.03%
Current ratio (mrq)0.52
Book value per share (mrq)392.82

Cash flow statement

Operating cash flow (ttm)-241.89B
Levered free cash flow (ttm)-267.05B